|
 |
|
|||||||
|
|||||||||
Copyright ©ERS Journals Ltd 2002
Impact of COPD in North America and Europe in 2000: subjects' perspective of Confronting COPD International Survey
1 University of Nebraska, Pulmonary and Critical Care Medicine Section, Omaha, NE, USA. 2 Respiratory Division, Catholic University of Leuven, Leuven, Belgium. 3 University of Liverpool, Dept of Medicine, Clinical Sciences Centre, University Hospital Aintree, Liverpool, UK. 4 Thoracic Medicine, National Heart and Lung Institute, Imperial College School of Medicine, London, UK. 5 Worldwide Epidemiology, GlaxoSmithKline Research and Development, Greenford, UK. 6 Dept of Respiratory Medicine, University of Antwerp, Antwerp, Belgium. 7 Dept of Respiratory Medicine, Hvidovre University Hospital, Copenhagen, Denmark
CORRESPONDENCE: S. Rennard, Pulmonary and Critical Care Medicine Section, University of Nebraska Medical Center, 985125 Nebraska Medical Center, Omaha, NE 68198-5125, USA. Fax: 1 402 5594878. E-mail: srennard@unmc.edu
Keywords: chronic obstructive pulmonary disease, epidemiology, guidelines, management, subject perspective
Received: December 10, 2001
Accepted May 1, 2002
This study was supported by GlaxoSmithKline Research and Development, Greenford, UK.
To date, no international surveys estimating the burden of chronic obstructive pulmonary disease (COPD) in the general population have been published. The Confronting COPD International Survey aimed to quantify morbidity and burden in COPD subjects in 2000.
From a total of 201,921 households screened by random-digit dialling in the USA, Canada, France, Italy, Germany, the Netherlands, Spain and the UK, 3,265 subjects with a diagnosis of COPD, chronic bronchitis or emphysema, or with symptoms of chronic bronchitis, were identified.
The mean age of the subjects was 63.3 yrs and 44.2% were female. Subjects with COPD in North America and Europe appear to underestimate their morbidity, as shown by the high proportion of subjects with limitations to their basic daily life activities, frequent work loss (45.3% of COPD subjects of <65 yrs reported work loss in the past year) and frequent use of health services (13.8% of subjects required emergency care in the last year), and may be undertreated. There was a significant disparity between subjects' perception of disease severity and the degree of severity indicated by an objective breathlessness scale. Of those with the most severe breathlessness (too breathless to leave the house), 35.8% described their condition as mild or moderate, as did 60.3% of those with the next most severe degree of breathlessness (breathless after walking a few minutes on level ground).
This international survey confirmed the great burden to society and high individual morbidity associated with chronic obstructive pulmonary disease in subjects in North America and Europe.
This article has been cited by other articles:
|
|
 |
|
  P. W. Jones, G. Harding, P. Berry, I. Wiklund, W-H. Chen, and N. Kline Leidy Development and first validation of the COPD Assessment Test Eur. Respir. J., September 1, 2009; 34(3): 648 - 654. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. R. Partridge, W. Schuermann, O. Beckman, T. Persson, and T. Polanowski Effect on lung function and morning activities of budesonide/formoterol versus salmeterol/fluticasone in patients with COPD Therapeutic Advances in Respiratory Disease, August 1, 2009; 3(4): 147 - 157. [Abstract] [PDF]
|
|
|
|
 |
|
 J Smith, P Albert, E Bertella, J Lester, S Jack, and P Calverley Qualitative aspects of breathlessness in health and disease Thorax, August 1, 2009; 64(8): 713 - 718. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S Dorman, C Jolley, A Abernethy, D Currow, M Johnson, M Farquhar, G Griffiths, T Peel, S Moosavi, A Byrne, et al. Researching breathlessness in palliative care: consensus statement of the National Cancer Research Institute Palliative Care Breathlessness Subgroup Palliative Medicine, April 1, 2009; 23(3): 213 - 227. [Abstract] [PDF]
|
|
|
|
 |
|
 S. I. Rennard and J. Vestbo Natural Histories of Chronic Obstructive Pulmonary Disease Proceedings of the ATS, December 15, 2008; 5(9): 878 - 883. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Rodriguez-Roisin and J. B. Soriano Chronic Obstructive Pulmonary Disease with Lung Cancer and/or Cardiovascular Disease Proceedings of the ATS, December 1, 2008; 5(8): 842 - 847. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. R. Celli Update on the Management of COPD Chest, June 1, 2008; 133(6): 1451 - 1462. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Roche, F. Dalmay, T. Perez, C. Kuntz, A. Vergnenegre, F. Neukirch, J-P. Giordanella, and G. Huchon Impact of chronic airflow obstruction in a working population Eur. Respir. J., June 1, 2008; 31(6): 1227 - 1233. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M Albers, T Schermer, Y Heijdra, J Molema, R Akkermans, and C van Weel Predictive value of lung function below the normal range and respiratory symptoms for progression of chronic obstructive pulmonary disease Thorax, March 1, 2008; 63(3): 201 - 207. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Viegi, F. Pistelli, D. L. Sherrill, S. Maio, S. Baldacci, and L. Carrozzi Definition, epidemiology and natural history of COPD Eur. Respir. J., November 1, 2007; 30(5): 993 - 1013. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Mannino and S. Braman The Epidemiology and Economics of Chronic Obstructive Pulmonary Disease Proceedings of the ATS, October 1, 2007; 4(7): 502 - 506. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. J. Martinez, J. L. Curtis, F. Sciurba, J. Mumford, N. D. Giardino, G. Weinmann, E. Kazerooni, S. Murray, G. J. Criner, D. D. Sin, et al. Sex Differences in Severe Pulmonary Emphysema Am. J. Respir. Crit. Care Med., August 1, 2007; 176(3): 243 - 252. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A Cleland, A. J Lee, and S. Hall Associations of depression and anxiety with gender, age, health-related quality of life and symptoms in primary care COPD patients Fam. Pract., June 1, 2007; 24(3): 217 - 223. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. E. O'Donnell, R. B. Banzett, V. Carrieri-Kohlman, R. Casaburi, P. W. Davenport, S. C. Gandevia, A. F. Gelb, D. A. Mahler, and K. A. Webb Pathophysiology of Dyspnea in Chronic Obstructive Pulmonary Disease: A Roundtable Proceedings of the ATS, May 1, 2007; 4(2): 145 - 168. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Madani, V. De Maertelaer, J. Zanen, and P. A. Gevenois Pulmonary Emphysema: Radiation Dose and Section Thickness at Multidetector CT Quantification--Comparison with Macroscopic and Microscopic Morphometry Radiology, April 1, 2007; 243(1): 250 - 257. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y.-C. Wang, J.-M. Lin, C.-Y. Li, L.-T. Lee, Y.-L. Guo, and F.-C. Sung Prevalence and Risks of Chronic Airway Obstruction: A Population Cohort Study in Taiwan Chest, March 1, 2007; 131(3): 705 - 710. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. M. A. Calverley Exercise and dyspnoea in COPD Eur. Respir. Rev., December 1, 2006; 15(100): 72 - 79. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. E. O'Donnell, F. Sciurba, B. Celli, D. A. Mahler, K. A. Webb, C. J. Kalberg, and K. Knobil Effect of Fluticasone Propionate/Salmeterol on Lung Hyperinflation and Exercise Endurance in COPD. Chest, September 1, 2006; 130(3): 647 - 656. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Stenfors Physician-Diagnosed COPD Global Initiative for Chronic Obstructive Lung Disease Stage IV in Ostersund, Sweden: Patient Characteristics and Estimated Prevalence. Chest, September 1, 2006; 130(3): 666 - 671. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. G. Halpin and M. Miravitlles Chronic Obstructive Pulmonary Disease: The Disease and Its Burden to Society Proceedings of the ATS, September 1, 2006; 3(7): 619 - 623. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Smith, E. Owen, J. Earis, and A. Woodcock Cough in COPD: Correlation of Objective Monitoring With Cough Challenge and Subjective Assessments. Chest, August 1, 2006; 130(2): 379 - 385. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Kessler, E. Stahl, C. Vogelmeier, J. Haughney, E. Trudeau, C.-G. Lofdahl, and M. R. Partridge Patient Understanding, Detection, and Experience of COPD Exacerbations: An Observational, Interview-Based Study. Chest, July 1, 2006; 130(1): 133 - 142. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. A. Mahler Mechanisms and Measurement of Dyspnea in Chronic Obstructive Pulmonary Disease Proceedings of the ATS, May 1, 2006; 3(3): 234 - 238. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. M. A. Calverley Dynamic Hyperinflation: Is It Worth Measuring? Proceedings of the ATS, May 1, 2006; 3(3): 239 - 244. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G C Donaldson and J A Wedzicha COPD exacerbations {middle dot} 1: Epidemiology Thorax, February 1, 2006; 61(2): 164 - 168. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. R. Chapman, D. M. Mannino, J. B. Soriano, P. A. Vermeire, A. S. Buist, M. J. Thun, C. Connell, A. Jemal, T. A. Lee, M. Miravitlles, et al. Epidemiology and costs of chronic obstructive pulmonary disease Eur. Respir. J., January 1, 2006; 27(1): 188 - 207. [Full Text] [PDF]
|
|
|
|
|
|
B. R. Celli Chronic Obstructive Pulmonary Disease: From Unjustified Nihilism to Evidence-based Optimism. Proceedings of the ATS, January 1, 2006; 3(1): 58 - 65. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Casaburi and J. Porszasz Reduction of hyperinflation by pharmacologic and other interventions. Proceedings of the ATS, January 1, 2006; 3(2): 185 - 189. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. J. Stevenson, P. P. Walker, R. W. Costello, and P. M. A. Calverley Lung Mechanics and Dyspnea during Exacerbations of Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., December 15, 2005; 172(12): 1510 - 1516. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Haughney, M. R. Partridge, C. Vogelmeier, T. Larsson, R. Kessler, E. Stahl, R. Brice, and C-G. Lofdahl Exacerbations of COPD: quantifying the patient's perspective using discrete choice modelling Eur. Respir. J., October 1, 2005; 26(4): 623 - 629. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M Decramer, R Gosselink, M Rutten-Van Molken, J Buffels, O Van Schayck, P-A Gevenois, R Pellegrino, E Derom, and W De Backer Assessment of progression of COPD: report of a workshop held in Leuven, 11-12 March 2004 Thorax, April 1, 2005; 60(4): 335 - 342. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M Decramer, R Gosselink, P Bartsch, C-G Lofdahl, W Vincken, R Dekhuijzen, J Vestbo, R Pauwels, R Naeije, and T Troosters Effect of treatments on the progression of COPD: report of a workshop held in Leuven, 11-12 March 2004 Thorax, April 1, 2005; 60(4): 343 - 349. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D A Seamark, S D Blake, C J Seamark, and D M. Halpin Living with severe chronic obstructive pulmonary disease (COPD): perceptions of patients and their carers: An interpretative phenomenological analysis Palliative Medicine, October 1, 2004; 18(7): 619 - 625. [Abstract] [PDF]
|
|
|
|
|
|
G. Viegi, G. Matteelli, A. Angino, A. Scognamiglio, S. Baldacci, J. B. Soriano, and L. Carrozzi The Proportional Venn Diagram of Obstructive Lung Disease in the Italian General Population Chest, October 1, 2004; 126(4): 1093 - 1101. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. A. Mahler, S. Huang, M. Tabrizi, and G. M. Bell Efficacy and Safety of a Monoclonal Antibody Recognizing Interleukin-8 in COPD: A Pilot Study Chest, September 1, 2004; 126(3): 926 - 934. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. M. A. Wilkinson, G. C. Donaldson, J. R. Hurst, T. A. R. Seemungal, and J. A. Wedzicha Early Therapy Improves Outcomes of Exacerbations of Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., June 15, 2004; 169(12): 1298 - 1303. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Buffels, J. Degryse, J. Heyrman, and M. Decramer Office Spirometry Significantly Improves Early Detection of COPD in General Practice: The DIDASCO Study Chest, April 1, 2004; 125(4): 1394 - 1399. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Tzanakis, U. Anagnostopoulou, V. Filaditaki, P. Christaki, and N. Siafakas Prevalence of COPD in Greece Chest, March 1, 2004; 125(3): 892 - 900. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J Vestbo COPD in the ECRHS Thorax, February 1, 2004; 59(2): 89 - 90. [Full Text] [PDF]
|
|
|
|
 |
|
 B. R. Celli A 62-Year-Old Woman With Chronic Obstructive Pulmonary Disease JAMA, November 26, 2003; 290(20): 2721 - 2729. [Full Text] [PDF]
|
|
|
|
|
|
M. Decramer Treatment of chronic respiratory failure: lung volume reduction surgery versus rehabilitation Eur. Respir. J., November 16, 2003; 22(47_suppl): 47s - 56s. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A.L. Hansell, J.A. Walk, and J.B. Soriano What do chronic obstructive pulmonary disease patients die from? Amultiple cause coding analysis Eur. Respir. J., November 1, 2003; 22(5): 809 - 814. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
The pharmacoepidemiology of COPD: Recent advances and methodological discussion Eur. Respir. J., September 1, 2003; 22(43_suppl): 1s - 44s. [Full Text] [PDF]
|
|
|
|
|
|
J. B. Soriano, K. J. Davis, B. Coleman, G. Visick, D. Mannino, and N. B. Pride The Proportional Venn Diagram of Obstructive Lung Disease: Two Approximations From the United States and the United Kingdom Chest, August 1, 2003; 124(2): 474 - 481. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.T. Weiss, D.L. DeMeo, and D.S. Postma COPD: problems in diagnosis and measurement Eur. Respir. J., June 1, 2003; 21(41_suppl): 4S - 12s. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.K. Connolly Chronic obstructive pulmonary disease: underdiagnosed, underinvestigated, inappropriately managed? Eur. Respir. J., March 1, 2003; 21(3): 556 - 557. [Full Text] [PDF]
|
|
|
|
|
|
P.N.R. Dekhuijzen The Confronting COPD International Survey: patients hardly know they have COPD Eur. Respir. J., October 1, 2002; 20(4): 793 - 794. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |